References
Ensor J. The artist’s mother in death [painting]. 1915. James Ensor: an online museum; Vlaamse Kunstcollectie [online]. Available from URL: http://jamesensor.vlaamsekunstcollectie.be/en/collection/the-artists-mother-in-death [Accessed 2011 Sep 27]
Oeppen J, Vaupel JW. Broken limits to life expectancy. Science 2002; 296(5570): 1029–31
Turner P. Clinical trial in elderly subjects. Postgrad Med J 1989; 65: 218–20
Yuquing Zhang, Xuezhong Zhang, Lisheng Liu, et al. Is a systolic blood pressure target <140 mmHg indicated in all hypertensives? Subgroup analyses of findings from the randomized FEVER trial. Eur Heart J 2011; 32: 1500–8
Grenier L, Barbeau G. Chapter 52. In: Arcand M, Hébert R, editors. Précis pratique de Gériatrie. Paris: Edisem, Maloine, 1997: 709–10
European Medicines Agency [online]. Available from URL: http://www.ema.europa.eu [Accessed 2011 Sep 27]
ICH Topic E7. Studies in support of special populations: geriatrics. Step 5: note for guidance on studies in support of special populations: geriatrics (CPMP/ICH/379/95). London: EMEA, 1994 Mar [online]. Available from URL: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002875.pdf [Accessed 2011 Sep 27]
Committee for Human Medicinal Products (CHMP). Adequacy of guidance on the elderly regarding medicinal products for human use (EMEA/498920/2006). London: EMEA, 2006 Dec 14 [online]. Available from URL: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500049541.pdf [Accessed 2011 Sep 27]
Medicines for older people. London: European Medicines Agency [online]. Available from URL: http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000249.jsp&murl=menus/special_topics/special_topics.jsp&mid=WC0b01ac058004cbb9 [Accessed 2011 Sep 29]
Committee for Human Medicinal Products (CHMP). ICH topic E7. Studies in support of special populations: geriatrics questions and answers. Step 5 (EMA/CHMP/ICH/604661/2009). London: EMEA, 2010 Jul [online]. Available from URL: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500005218.pdf [Accessed 2011 Sep 27]
Cherubini A, Del Signore S, Ouslander J, et al. Fighting against age discrimination in clinical trials. J Am Geriatr Soc 2010 Sep; 58(9): 1791–6
EMA geriatric medicines strategy (EMA/CHMP/137793/2011). London: EMEA, 2011 Feb 17 [online]. Available from URL: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2011/02/WC500102291.pdf [Accessed 2011 Sep 27]
Revision of the clinical trials directive, 2001/20/EC. Brussels: AGE Platform Europe, 2011 May 11 [online]. Available from URL: http://www.age-platform.eu/images/stories/AGE_ContributionClinicalTrials_May2011.pdf [Accessed 2011 Sep 27]
Acknowledgements
No sources of funding were used to assist in the preparation of this article. The author has no conflicts of interest that are directly relevant to the content of this article. Jean-Pierre Baeyens is a representative of the EUGMS at the Health Care Professionals Working Group at the EMA.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Baeyens, JP. The European Medicines Agency Discovers the Geriatric Patient. Drugs Aging 28, 849–851 (2011). https://doi.org/10.2165/11597810-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11597810-000000000-00000